TD Asset Management »

Terns Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $850k 99k 8.55

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Canadian Pacific Kansas City (CP)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Broadcom (AVGO)
Canadian Natural Resources (CNQ)
Cibc Cad (CM)
UnitedHealth (UNH)

View all positions for TD Asset Management

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
BlackRock
Citadel Advisors
VR Adviser
Schonfeld Strategic Advisors
Point72 Asset Management
Vanguard Group
Avidity Partners Management
Driehaus Capital Management
ExodusPoint Capital Management
T. Rowe Price Associates
Geode Capital Management

View all funds holding Terns Pharmaceuticals